ARG1 and neoplasm: Inhibition of Arg1 via CB-1158 prevented MDSC-mediated suppression of T cell proliferation in vitro, and reduced tumour growth in multiple murine models of cancer via potentiating the effects of the chemotherapy gemcitabine and immunotherapies including immune checkpoint inhibitors, adoptive T cell or NK cell transfer [38].